XML 18 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Dec. 26, 2015
Dec. 27, 2014
Cash flows from operating activities:    
Net income $ 355 $ 578
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 227 219
Deferred income tax benefit (4) (11)
Equity in losses of equity-method investees 7 9
Non-cash stock-based compensation expense 79 60
Non-cash impairment of assets 24 2
Excess tax benefits from stock-based compensation arrangements (9) (7)
Other non-cash charges, net 20 (20)
Changes in operating assets and liabilities:    
Accounts receivable 176 155
Inventories (251) (240)
Prepaid expenses and other current assets 24 (77)
Accounts payable and accrued liabilities 218 101
Income tax receivables and payables 0 101
Deferred income (8) (13)
Other balance sheet changes, net (6) 33
Net cash provided by operating activities 852 890
Cash flows from investing activities:    
Capital expenditures (325) (300)
Purchases of investments (637) (1,156)
Proceeds from sales and maturities of investments 591 940
Acquisitions and ventures (14) (8)
Change in restricted cash deposits (6) (1)
Net cash used in investing activities (391) (525)
Cash flows from financing activities:    
Proceeds from issuance of short-term debt 3,409 2,283
Repayments of short-term debt (3,628) (2,170)
Proceeds from issuance of long-term debt 299 0
Payments of capital lease obligations (19) (17)
Payments of dividends (128) (119)
Repurchases of common stock, including shares surrendered for tax withholdings (399) (382)
Proceeds from exercises of stock options 31 46
Excess tax benefits from stock-based compensation arrangements 9 7
Other financing activities (2) 0
Net cash used in financing activities (428) (352)
Effect of exchange rate changes on cash and cash equivalents (6) (47)
Net increase (decrease) in cash and cash equivalents 27 (34)
Cash and cash equivalents at beginning of period 500 797
Cash and cash equivalents at end of period $ 527 $ 763